Humana (HUM)
237.96
+10.49 (4.61%)
NYSE · Last Trade: May 18th, 3:57 AM EDT
Detailed Quote
Previous Close | 227.47 |
---|---|
Open | 229.74 |
Bid | 239.50 |
Ask | 241.00 |
Day's Range | 228.00 - 239.13 |
52 Week Range | 212.45 - 406.46 |
Volume | 2,571,972 |
Market Cap | 30.58B |
PE Ratio (TTM) | 16.81 |
EPS (TTM) | 14.2 |
Dividend & Yield | 3.540 (1.49%) |
1 Month Average Volume | 1,977,142 |
Chart
About Humana (HUM)
Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
News & Press Releases
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via Chartmill · May 16, 2025
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
Via Chartmill · May 16, 2025
Jim Cramer weighed in on the deepening crisis at one of America's largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media.
Via Benzinga · May 16, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · May 15, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · May 15, 2025
A team of experienced mental health professionals has launched Tulsa Metro Psychiatry (918-982-6524), a full-service practice offering diagnostic evaluations, medication management, and counseling services for patients across all age groups.
Via Press Release Distribution Service · May 15, 2025
Stay tuned for the market movements in the S&P500 index on Thursday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · May 15, 2025
Empire Psychiatry, a fast-rising name in the world of mental wellness, is proud to announce its launch as New York’s go-to destination for thoughtful, personalized psychiatric care. With a commitment to making mental health services more accessible, human-centered, and stigma-free, Empire Psychiatry is already making waves among patients and practitioners alike.
Via GetFeatured · May 14, 2025
Tech stocks lead Wall Street higher as trade tensions ease and inflation cools. Tesla and Nvidia reach key valuation milestones.
Via Chartmill · May 14, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill · May 13, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · May 13, 2025
Stay tuned for the market movements in the S&P500 index on Tuesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Via Chartmill · May 13, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
Health insurance company Humana (NYSE:HUM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $32.11 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $11.58 per share was 15% above analysts’ consensus estimates.
Via StockStory · May 13, 2025
Curious about the S&P500 stocks that are showing activity before the opening bell on Tuesday?
Via Chartmill · May 13, 2025
CenterWell Specialty Pharmacy has once again received the MMIT Specialty Pharmacy Patient Choice Award in the PBM/Payer category, its seventh such win in the past eight years. The award recognizes best-in-class customer satisfaction and commitment to patient care by a specialty pharmacy.
By Humana Inc. · Via Business Wire · May 13, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
The lawsuit alleges that from 2016 through at least 2021, the insurers paid hundreds of millions of dollars in illegal kickbacks to brokers.
Via Benzinga · May 5, 2025
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
Humana beat Q1 EPS estimates with $11.58, reaffirmed 2025 guidance, and outlined margin goals despite a drop in Medicare Advantage membership.
Via Benzinga · April 30, 2025
Wall Street traded lower on the final session of the month, heading for its third consecutive monthly loss as economic data began reflecting the impact of Trump tariffs.
Via Benzinga · April 30, 2025
Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.
Via Chartmill · April 30, 2025
Health insurance company Humana (NYSE:HUM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.4% year on year to $32.11 billion. The company’s full-year revenue guidance of $127 billion at the midpoint came in 0.7% above analysts’ estimates. Its GAAP profit of $10.30 per share was 3.4% above analysts’ consensus estimates.
Via StockStory · April 30, 2025